Loose skin after Ozempic is a cosmetic concern that can arise following significant weight loss, rather than a direct effect of the medication itself. Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, which works by enhancing insulin secretion, suppressing appetite, and slowing gastric emptying. These mechanisms often lead to weight reduction, and when weight loss occurs rapidly or substantially, the skin may lack sufficient time to adapt to the body's new contours. Skin elasticity depends on collagen and elastin fibres, which can become damaged during prolonged stretching and may not fully contract after fat loss. This article explores why loose skin develops, how common it is, prevention strategies, available treatments, and when to seek medical advice.

Why Does Ozempic Cause Loose Skin?

Ozempic (semaglutide) does not directly cause loose skin — rather, it is the rapid and substantial weight loss associated with the medication that can lead to skin laxity. Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK specifically for the treatment of type 2 diabetes mellitus, not for weight management (for which semaglutide is available as Wegovy). Ozempic works by enhancing glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways. These mechanisms often result in weight reduction, which is beneficial for metabolic health but can have cosmetic consequences.

When individuals lose weight quickly — particularly large amounts over a short period — the skin may not have sufficient time to adapt to the body's new contours. Skin elasticity depends on collagen and elastin fibres within the dermis, which provide structural support and allow the skin to stretch and recoil. During periods of weight gain, the skin expands to accommodate increased subcutaneous fat. However, prolonged stretching can damage these fibres, and when fat is lost rapidly, the skin may lack the elasticity needed to contract fully, resulting in loose or sagging skin.

Several factors influence the degree of skin laxity experienced after weight loss, including the amount of weight lost, the speed of weight loss, age, genetics, skin quality, and duration of obesity. Older individuals and those who have carried excess weight for many years are more likely to experience loose skin because collagen production naturally declines with age, and chronic stretching reduces the skin's ability to recover. There is no official link between Ozempic itself and impaired skin elasticity — the phenomenon is a consequence of the weight loss process rather than a direct pharmacological effect of semaglutide.

How Common Is Loose Skin After Weight Loss with Ozempic?

The prevalence of loose skin following Ozempic-associated weight loss is not formally documented in clinical trial data, as cosmetic outcomes are not typically primary endpoints in diabetes or obesity trials. The frequency of this issue is therefore not well established in the scientific literature.

Clinical studies show different weight loss outcomes depending on whether semaglutide is used for diabetes (Ozempic) or weight management (Wegovy). In type 2 diabetes trials (SUSTAIN programme), Ozempic typically produced average weight loss of approximately 4-7% of body weight. By comparison, Wegovy, which is specifically licensed for weight management at a higher dose, demonstrated average weight loss of approximately 15% in the STEP trials for people with obesity or overweight.

Based on clinical experience and observations from weight loss through various methods, individuals who lose significant weight may develop noticeable skin laxity. Factors that may influence this include:

• The total amount of weight lost

• Age (older individuals typically have less skin elasticity)

• History of weight fluctuations

• Duration of overweight or obesity (years or decades)

• Inherent skin elasticity influenced by genetics, smoking, or sun damage

It is important to recognise that not everyone who loses weight on Ozempic will develop loose skin. Younger individuals with good skin quality and those who lose weight more gradually may experience minimal or no skin laxity. Additionally, the distribution of weight loss matters — fat loss from areas such as the abdomen, upper arms, thighs, and breasts is more likely to result in visible loose skin compared to more evenly distributed fat reduction.

Patients should be aware that loose skin is a potential cosmetic consequence of successful weight loss, but it does not indicate any harm to overall health. The metabolic and cardiovascular benefits of weight reduction, including improved glycaemic control, reduced cardiovascular risk, and enhanced quality of life, remain the primary therapeutic goals of Ozempic treatment.

Can You Prevent Loose Skin While Taking Ozempic?

While it may not be possible to completely prevent loose skin during significant weight loss, several strategies may help minimise its severity by supporting skin health and promoting gradual, sustainable weight reduction.

Gradual weight loss is one of the most important factors. Losing weight at a moderate pace — typically 0.5 to 1 kg per week — allows the skin more time to adapt to changes in body composition. However, patients should always follow their prescriber's guidance for Ozempic titration according to the product information, as dosing should be adjusted based on glycaemic control and tolerability, not to control weight loss rate.

Resistance training and strength exercises are crucial for preserving lean muscle mass during weight loss. Muscle provides structural support beneath the skin, helping to fill out areas that might otherwise appear loose or saggy. The UK Chief Medical Officers' Physical Activity Guidelines recommend muscle-strengthening activities on at least two days per week, alongside cardiovascular activity, to improve body composition and overall health.

Adequate protein intake supports both muscle maintenance and collagen synthesis. Higher protein diets may help preserve lean mass during weight loss, particularly when combined with resistance exercise. Good sources include lean meats, fish, eggs, dairy, legumes, and plant-based proteins. Patients with kidney disease should seek advice from a dietitian before increasing protein intake.

Hydration and skin care also play supportive roles. Drinking sufficient water helps maintain skin turgor and overall health, while moisturisers may support skin health. Although evidence for topical treatments reversing established loose skin is limited, regular moisturising can help maintain skin condition.

Finally, avoiding smoking and excessive sun exposure is essential, as both accelerate collagen breakdown and reduce skin elasticity. Patients should use broad-spectrum sunscreen daily and consider smoking cessation support if applicable. While these measures cannot guarantee prevention of loose skin, they represent evidence-based approaches to optimising skin health during weight loss.

Treatment Options for Loose Skin After Ozempic

For individuals who develop loose skin after weight loss with Ozempic, several treatment options are available, ranging from non-invasive therapies to surgical interventions. The choice depends on the severity of skin laxity, patient preferences, overall health, and financial considerations, as many cosmetic procedures are not available on the NHS.

Non-surgical treatments may offer modest improvements for mild to moderate skin laxity. These include:

• Radiofrequency and ultrasound devices that deliver controlled heat to deeper skin layers, stimulating collagen remodelling and tightening over several months

• Laser treatments that promote collagen production and improve skin texture

• Microneedling with radiofrequency, which combines mechanical injury with thermal energy to enhance skin tightening

These treatments typically require multiple sessions and produce gradual, subtle results. They are most effective for individuals with mild laxity and reasonable baseline skin quality. Results vary considerably between individuals, and there is no guarantee of significant improvement.

Surgical options provide more dramatic and permanent results for moderate to severe loose skin. Common procedures include:

• Abdominoplasty (tummy tuck) for excess abdominal skin

• Brachioplasty (arm lift) for upper arm laxity

• Thigh lift for inner or outer thigh skin

• Lower body lift for circumferential trunk and thigh laxity

• Breast lift (mastopexy) or breast augmentation for volume loss and sagging

Body contouring surgery is typically considered once weight has been stable for at least 6-12 months to ensure results are not compromised by further weight changes. These procedures carry surgical risks including infection, scarring, bleeding, seroma (fluid collection), delayed wound healing, venous thromboembolism, and anaesthetic complications. Smoking cessation is usually required before surgery. Patients should have realistic expectations about outcomes and recovery.

In the UK, cosmetic body contouring is rarely funded by the NHS unless there is functional impairment (e.g., recurrent skin infections, mobility issues) or significant psychological distress. Funding decisions are made by local Integrated Care Boards (ICBs) through Individual Funding Request (IFR) processes. Patients considering surgery should consult with a surgeon registered with the General Medical Council (GMC) and ideally a member of the British Association of Aesthetic Plastic Surgeons (BAAPS) or British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS).

When to Speak to Your GP About Skin Changes

While loose skin after weight loss is primarily a cosmetic concern, certain skin changes warrant medical evaluation to rule out complications or underlying conditions.

Patients should contact their GP if they experience:

• Recurrent skin infections (bacterial or fungal) in skin folds, which may present as redness, warmth, pain, discharge, or odour. Intertrigo and cellulitis can develop in areas where loose skin creates persistent moisture and friction

• Persistent rashes, irritation, or breakdown of the skin that does not respond to basic hygiene and barrier creams

• Significant functional impairment, such as difficulty with mobility, exercise, or daily activities due to excess skin

• Psychological distress affecting quality of life, self-esteem, or mental health. GPs can provide appropriate support, counselling referrals, or discuss whether NHS funding for body contouring might be considered in exceptional circumstances

• Unexplained lumps, changes in skin texture, or new lesions, which should always be evaluated to exclude malignancy or other dermatological conditions

Additionally, patients taking Ozempic should report any suspected side effects to their prescribing clinician, including gastrointestinal symptoms (nausea, vomiting, diarrhoea), signs of pancreatitis (severe abdominal pain radiating to the back), gallbladder problems (right upper abdominal pain, fever, yellowing of skin/eyes), dehydration, or worsening of diabetic retinopathy. Patients taking Ozempic alongside sulfonylureas or insulin should be aware of increased hypoglycaemia risk. Suspected adverse reactions can also be reported via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).

For individuals considering cosmetic treatments for loose skin, discussing options with a GP first can be helpful. GPs can provide realistic expectations, discuss the risks and benefits of various approaches, and offer referrals to appropriate specialists when indicated. They can also review whether continued Ozempic therapy is appropriate based on diabetes control, weight loss goals, and overall health status.

Finally, patients should be reassured that loose skin does not indicate treatment failure — rather, it reflects successful weight loss and the body's natural response to significant compositional change. The metabolic benefits of weight reduction, including improved glycaemic control, reduced cardiovascular risk, and enhanced quality of life, remain the primary therapeutic goals of Ozempic treatment.

Frequently Asked Questions